New approaches for Parkinson's Disease
Article Sidebar
Main Article Content
Abstract
Parkinson's disease is a neurodegenerative disease with death of dopaminergic neurons in the nigrostriatal complex. The parkin gene appears to be the pivot element that Parkinson's responsibility, even if this were changes in juvenile parkinsonism. But there are many genes and mutations that act in the human body and cause degenerative disease or dopaminergic neuronal death.
Downloads
Article Details
The main author must deliver the letter of transfer of copyright, according to the model provided by Vivat Academia, Revista de comunicación, which declares the transfer of copyright to the journal and make explicit the rights of authors regarding the dissemination and use of the manuscript once published.
Creative Commons Attribution/Non Commercial 4.0 International
References
Parkin: A Multipurpose Neuroprotective Agent?. Mel B. Feany and Leo J: Pallank et al. Neuron, Vol. 38,13-16,10 abril 2003.
Pathways to Parkinsonism. Mark R. Cookson et al. Neuron Vol. 37, 7-10, 9 enero,2003.. Neuron, Vol. 36, 1007-1019, 19 diciembre 2003.
Genetic or Pharmacological Iron Chelation Prevents MPTP-Induced Neurotoxicity In Vivo: A Novel Therapy for Parkinson's Disease. Neuron Vol. 37, 899-909,27 marzo,
Parkin Protects against the Toxicity Associated with Mutant a-synuclein: Proteasome Dysfunction Selectively Affects Catecholaminergic Neurons.